Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 2Hepatoblastoma 2Colorectal Neoplasms 2Wilms Tumor 1Testicular Neoplasms 1Teratoma 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Retinoblastoma 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Neuroectodermal Tumors 1Neuroblastoma 1Medulloblastoma 1Locally Advanced Rectal Cancer 1Liver Neoplasms 1Kidney Neoplasms 1Glioma 1Ependymoma 1Desmoplastic Small Round Cell Tumor 1Colonic Neoplasms 1Chordoma 1Central Nervous System Neoplasms 1Brain Neoplasms 1Astrocytoma 1

Interventions

Capecitabine 20Oxaliplatin 13Irinotecan 8spartalizumab 6tislelizumab 4Radiation 4Neoadjuvant Therapy 4Immune Checkpoint Inhibitors 4Fluorouracil 4toripalimab 3sintilimab 2camrelizumab 2Radiotherapy 2Leucovorin 2Celecoxib 2veliparib 1peposertib 1nimotuzumab 1irinotecan sucrosofate 1XELOX 1Thymalfasin 1Radiotherapy, Intensity-Modulated 1Injections 1HMPL-013 1Folfox protocol 1Diathermy 1Combined Modality Therapy 1Chemoradiotherapy 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Rectal Cancer × Amifostine × Gastrointestinal × Clear all
NCT03702985 2019-01-23

Radiation-protection Effect of Amifostine in Locally Advanced Rectal Cancer

Fudan University

Phase 2 Unknown
160 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡